The Chinese University of Hong Kong

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1963-01-01

Employees: -

Market Cap: -

Website: http://www.cuhk.edu.hk

Clinical Trials

A Trial to Investigate the Impact of a Low Glycemic Index (GI) Diet on Body Mass Index and Obesity Related Cardiovascular and Hormonal Factors in Chinese Adolescents

Not Applicable

Conditions: Adolescence Obesity

First Posted Date: 2011-01-19

Last Posted Date: 2011-01-19

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 280

Registration Number: NCT01278563

Locations: 🇭🇰
Clinical Trial Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, Hong Kong

Prevention of Recurrent Ulcer Bleeding in High-risk Users of Low-dose Aspirin

Completed

Conditions: Ulcer Hemorrhage

First Posted Date: 2011-01-19

Last Posted Date: 2015-08-13

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 503

Registration Number: NCT01278550

Locations: 🇨🇳
Prince of Wales Hospital, Hong Kong (SAR), China

Prevalence Study of Depression in Chinese Patients With Type 2 Diabetes (HK13)

Completed

Conditions: Depression
Diabetes

Interventions: Other: Psychiatrist Interview
Other: Depression screening - control

First Posted Date: 2011-01-17

Last Posted Date: 2015-08-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 3218

Registration Number: NCT01277432

Locations: 🇨🇳
Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
🇨🇳
Shanghai Sixth People's Hospital, Shanghai, China
🇨🇳
Peking Union Hospital, Beijing, China

and more 4 locations

Prevention of Recurrent Ulcer Bleeding in High-risk Aspirin Users Who Are Not Infected With Helicobacter Pylori

Completed

Conditions: Ulcer Bleeding

First Posted Date: 2011-01-12

Last Posted Date: 2017-04-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 467

Registration Number: NCT01274767

Locations: 🇨🇳
Prince of Wales Hospital, Hong Kong, China

JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Janumet, Lantus
Drug: metformin, gliclazide, protaphane

First Posted Date: 2011-01-05

Last Posted Date: 2015-08-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 71

Registration Number: NCT01269996

Locations: 🇭🇰
Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

Whole Soy and Daidzein on Reduction of Blood Pressure in Postmenopausal Chinese Women

Not Applicable

Conditions: Hypertension

Interventions: Dietary Supplement: milk powder
Dietary Supplement: Whole soy (soy flour)
Dietary Supplement: daidzein

First Posted Date: 2011-01-05

Last Posted Date: 2011-01-05

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 270

Registration Number: NCT01270737

Locations: 🇨🇳
Center of Research and Promotion of Women's Health, Hong Kong, China

Modified Vaccinia Ankara (MVA) Vaccine Study

Phase 1

Completed

Conditions: Nasopharyngeal Neoplasms
Epstein-Barr Virus Infections

Interventions: Drug: MVA Vaccine

First Posted Date: 2010-12-09

Last Posted Date: 2011-12-22

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 18

Registration Number: NCT01256853

Locations: 🇭🇰
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Hepatocellular Carcinoma (HCC)_Torisel_

Phase 1

Completed

Conditions: Inoperable HCC

Interventions: Drug: Torisel

First Posted Date: 2010-12-02

Last Posted Date: 2016-09-28

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 46

Registration Number: NCT01251458

Locations: 🇭🇰
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Nasopharyngeal Carcinoma (NPC) Axitinib

Phase 2

Completed

Conditions: Recurrent or Metastatic NPC

Interventions: Drug: axitinib

First Posted Date: 2010-11-30

Last Posted Date: 2017-04-25

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 37

Registration Number: NCT01249547

Locations: 🇭🇰
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Intermittent Versus Continuous Tarceva Study

Phase 2

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: Chemotherapy

First Posted Date: 2010-11-18

Last Posted Date: 2012-11-22

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 60

Registration Number: NCT01243047

Locations: 🇭🇰
Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy